Cargando…
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease 2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review are to establish the association between COVID-19 and COVID-19 vaccines with the development of HVS. HVS may develop in var...
Autores principales: | Al-kuraishy, Hayder M., Al-Gareeb, Ali I., El-Bouseary, Maisra M., Sonbol, Fatma I., Batiha, Gaber El-Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128329/ https://www.ncbi.nlm.nih.gov/pubmed/35608715 http://dx.doi.org/10.1007/s10238-022-00836-x |
Ejemplares similares
-
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023) -
The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail
por: Alkhayyat, Shadi Salem, et al.
Publicado: (2022)